Data as of Dec 06
| -0.38 / -0.68%|
The 7 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 90.00, with a high estimate of 109.00 and a low estimate of 55.00. The median estimate represents a +63.01% increase from the last price of 55.21.
The current consensus among 8 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.